Abigail Brooks is an assistant editor for HCPLive. She joined MJH Life Sciences in August 2023 shortly after graduating from Monmouth University where she earned her BA in Communication with a concentration in Public Relations/Journalism and later an MA in Interactive Digital Media. She enjoys traveling, running, and reading books. She can be reached at abrooks@mjhlifesciences.com.
ODESSA-UC Study Compares Dose Escalation in Vedolizumab, AntiTNF-α for Ulcerative Colitis
December 2nd 2023Results showed patients treated with vedolizumab experienced less dose escalation and were at a decreased risk of requiring dose escalation compared to patients treated with adalimumab and infliximab.
Read More
Study Details Ultrasound Prevalence, Clinical Features of NAFLD in Patients with IBD
November 29th 2023The ultrasound prevalence of NAFLD was 23% among a cohort of patients with IBD, with study results further identifying several clinical characteristics associated with IBD-NAFLD including age, gender, BMI, and waist circumference.
Read More
Black Patients Receive Less C Diff Tests Despite Similar Positivity Rates to White Patients
November 27th 2023A retrospective cohort study of inpatient encounters from 3 hospitals in the Duke University Health System showed greater rates of testing among White patients compared to Black and NWNB patients.
Read More
Pegozafermin Shows Sustained Benefit for NASH in Phase 2b Extension Study
November 27th 2023Results from the 24-week extension period of the phase 2b ENLIVEN trial showed sustained improvements in liver fat, fibrosis, and inflammation among those treated with 30 mg weekly and 44 mg biweekly pegozafermin.
Read More
Q&A: The Microbiome and Autoimmune Liver Disease, with Gideon Hirschfield, PhD, MB BChir
November 25th 2023Gideon Hirschfield, PhD, MB BChir, Lily and Terry Horner Chair in Autoimmune Liver Disease Research at the University of Toronto, sat down with HCPLive Hepatology to discuss the role of the microbiome in autoimmune liver disease.
Read More
Q&A: Combination OCA-Bezafibrate for PBC, with Cynthia Levy, MD
November 23rd 2023Cynthia Levy, MD, professor of medicine at the University of Miami, provided further insight into unmet needs in PBC, the use of OCA-bezafibrate in PBC, and the significance of results from a pair of phase 2 studies presented at The Liver Meeting.
Read More
Empagliflozin Reduces Liver Fat Content Regardless of T2DM, Study Finds
November 15th 2023Findings were presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases and showed empagliflozin reduced liver fat content in both patients with T2DM and nondiabetic patients.
Read More
History of Hepatocellular Carcinoma Increases Risk of Liver-Related Mortality After SVR
November 13th 2023Results from this prospective study in Japan found older age, history of hepatocellular carcinoma, and decreased albumin level at SVR were significantly associated with liver-related mortality after SVR.
Read More
Food Insecurity, Household Income Associated with Risk of NAFLD in Adolescents
November 12th 2023Results presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases highlighted an association between food insecurity and low household income with the risk of NAFLD in adolescents.
Read More